COMPASS THERAPEUTICS, INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $30.6M | $43.5M | $24.2M | $34.9M | $144.5M | $47.1M | $25.3M | — |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $209.8M | $132.8M | $153.9M | $194.8M | $147.1M | $50.2M | $26.2M | $25 |
| Property, Plant & Equipment | $102.0K | $353.0K | $898.0K | $1.6M | $2.2M | $1.1M | $3.8M | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $219.6M | $140.4M | $156.9M | $199.6M | $153.8M | $51.9M | $30.4M | $25 |
| Liabilities | ||||||||
| Accounts Payable | $1.6M | $2.2M | $4.1M | $3.4M | $867.0K | $1.1M | $629.0K | — |
| Total Current Liabilities | $14.0M | $8.9M | $7.8M | $16.2M | $10.6M | $10.1M | $9.8M | $34.6K |
| Long-Term Debt | — | — | — | — | $0 | $1.9M | $9.3M | — |
| Total Liabilities | $22.8M | $15.2M | $8.3M | $18.0M | $13.7M | $12.0M | $19.1M | $34.6K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-431.2M | $-364.7M | $-315.3M | $-272.8M | $-233.6M | $-151.4M | $-121.9M | $-35.1K |
| Total Stockholders' Equity | $196.8M | $125.2M | $148.5M | $181.6M | $140.1M | $39.9M | $11.3M | $-84.8M |